Abstract
Synthetic procedures are described that allow access to the new complexes cis-[Mo2O5(apc)2], cis-[WO2(apc)2], trans-[UO2(apc)2], [Ru(apc)2(H2O)2], [Ru(PPh3)2(apc)2], [Rh(apc)3], [Rh(PPh3)2(apc)2]ClO4, [M(apc)2], [M(PPh3)2(apc)]Cl, [M(bpy)(apc)]Cl (M(II) = Pd, Pt), [Pd(bpy)(apc)Cl], [Ag(apc)(H2O)2] and [Ir(bpy)(Hapc)2]Cl3, where Hapc, is 3-aminopyrazine-2-carboxylic acid. These complexes were characterized by physico-chemical and spectroscopic techniques. Both Hapc and several of its complexes display significant anticancer activity against Ehrlich ascites tumour cells (EAC) in albino mice.
Similar content being viewed by others
References
Pratt WB, Ruddon RW, Ensminger WD, Maybaum J (1994) The anticancer drugs. Oxford University Press, New York, p 133
Krakoff IH, Nicolini M (eds) (1988) Platinum and other metal coordination compounds in cancer chemotherapy. Martinus Nijhoff, Boston, MA, p 351
Harrap KR, Muggia FM (eds) (1983) Cancer chemotherapy, vol 1. Martinus Nijhoff, Boston, MA, p 171
Mostafa SI, Hadjiliadis N (2008) Transition Met Chem 33:529
Mostafa SI, Badria F (2008) Met Based Drugs doi:10.1155/2008/723634
Mostafa SI, Papatriantafyllopoulou C, Perlepes S, Hadjiliadis N (2008) Bioinorg Chem Appl (in press)
Mostafa SI, Kabil MA, Saad EM, El-Asmy A (2006) J Coord Chem 59:279. doi:10.1080/00958970500266149
Endredi CH, Billes F, Holly S (2003) J Mol Struct Theochem 633:73. doi:10.1016/S0166-1280(03)00329-4
Ding B, Yankg E, Guo J, Zhao X, Wang X (2008) Inorg Chem Commun 11:509. doi:10.1016/j.inoche.2008.01.018
Tanase S, Van Son M, Gerard A, Gelder R, Bouwman E, Reedijk J (2006) Polyhedron 15:2967. doi:10.1016/j.poly.2006.04.024
Pawlukojc A, Natkaniec I, Malarski Z, Leciejewicz J (2000) J Mol Struct 516:7. doi:10.1016/S0022-2860(99)00130-1
Leciejewicz J, Ptasiewicz-Back H, Paluchowska B (1997) Pol J Chem 71:1359
Ptasiewicz-Back H, Leciejewicz J (1997) Pol J Chem 71:1350
Cookson RC, Jones DW (1965) J Chem Soc 1881. doi:10.1039/jr9650001881
Bailar JC, Itatani H (1965) Inorg Chem 4:1618. doi:10.1021/ic50033a019
Griffith WP, Mostafa SI (1992) Polyhedron 11:871. doi:10.1016/S0277-5387(00)83334-3
Stephenson TA, Wilkinson G (1966) J Inorg Nucl Chem 28:945. doi:10.1016/0022-1902(66)80191-4
Sheeji KR, Kuttan G, Kuttan R (1997) Amala Res Bull 17:73
Ardalan B, Buscagila MD, Schein PS (1978) Biochem Pharmacol 27:2009. doi:10.1016/0006-2952(78)90059-X
Mostafa SI (2007) Transition Met Chem 32:769
Sukanya D, Prabhakaran R, Natarajan K (2006) Polyhedron 25:2223. doi:10.1016/j.poly.2006.01.023
Gonzalez-Baro AC, Castellano EE, Piro OE, Parajon-Costa BS (2005) Polyhedron 24:49. doi:10.1016/j.poly.2004.09.032
Mostafa SI, Abd El-Maksoud S (1998) Monatsh Chem 129:455
De Fernandes AG, Deflon VM, De Souza EJ, Sa Maaia PI, Batista AA, Lemos SS, Abram U, Ellena J, Casrellano EE (2008) Polyhedron 27 (in press)
Boudalis AK, Nastopoulos V, Perlepes SP, Raptopoulou CP, Terzis A (2001) Transition Met Chem 26:276
Mostafa SI, Perlepes SP, Hadjiliadis N (2001) Z Naturforsch 56b:394
Nakamoto K (1986) Infrared and Raman spectra of inorganic and coordination compounds, 4th edn. Wiley, New York
Mostafa SI (1998) Transition Met Chem 23:397
Li YT, Jan CW, Zheng YJ, Liao DZ (1998) Polyhedron 17:1423. doi:10.1016/S0277-5387(97)00424-5
Mostafa SI (2008) J Coord Chem 61:1553. doi:10.1080/00958970701598977
Govindaswamy P, Therrien B, Fink G, Stepnicka P, Ludvik J (2007) J Organomet Chem 692:1661. doi:10.1016/j.jorganchem.2006.12.040
Lever ABP (1984) Inorganic electronic spectroscopy. El-Sevier, New York
Basu S, Peng S, Lee G, Bhattacharya S (2005) Polyhedron 24:157. doi:10.1016/j.poly.2004.10.015
Maurya MR, Jayaswal MN, Puranik VG, Chakrabarti P, Gopinathan S, Gopinathan C (1997) Polyhedron 16:3977. doi:10.1016/S0277-5387(97)00187-3
Yoshisue K, Hironaga Z, Yamaguchi S, Yamamoto A, Nagayama S, Kawaguchi Y (2000) Cancer Chemother Pharmacol 46:51. doi:10.1007/s002800000123
Romerosa A, Bergamini P, Bertolasi V, Canella A, Cattabriga M, Gavioli R, Manas S, Mantovani N, Pellacani L (2004) Inorg Chem 43:905. doi:10.1021/ic034868c
Osinsky S (1998) Ukr Patent Appl No. 981,27,052
Osinsky S, Levitin I, Bubnovskaya L, Sigan A, Ganusevich I, Michailenko V, Kovelskaya T (2000) INABIS Poster No. 33, vol 1
Sur P, Ganguly DK (1994) Planta Med 60:106. doi:10.1055/s-2006-959427
Acknowledgements
We wish to thank Prof. F. Badria (Liver Lab., Faculty of Pharmacy, Mansoura University, Egypt) for his assistance in the anticancerous measurements and Dr. A. Atwan (FRCSed) for the valuable discussion of this section.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gabr, I.M., El-Asmy, H.A., Emmam, M.S. et al. Synthesis, characterization and anticancer activity of 3-aminopyrazine-2-carboxylic acid transition metal complexes. Transition Met Chem 34, 409–418 (2009). https://doi.org/10.1007/s11243-009-9210-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11243-009-9210-3